To reinforce our team in Wädenswil, Switzerland, we are seeking a Postdoc or PhD position in Computational Cancer Genomics .
Postdoc or PhD position in Computational Cancer Genomics


Zurich University of Applied Sciences (ZHAW)

Work Location

Wädenswil, Switzerland

Employment fraction

50% - 100%

Type of contract


Job tasks

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers world-wide. Despite decades of research, 5-year survival for CRC patients is only 60%, and there exist few molecular biomarkers and treatment options. We are looking for a postdoc or a PhD student who will focus on modeling microsatellite changes in CRC somatic mutagenesis, as part of a collaborative SNSF Sinergia project “Trans-omic approach to colorectal cancer: an integrative computational and clinical perspective”. The overall aim of the project is to improve colorectal cancer patient stratification, prognosis and treatment prediction using an integrated approach to trans-omic data.

The successful candidate will work in the Applied Computational Genomics Team lead by Maria Anisimova at the Institute of Applied Simulations, Zurich University of Applied Sciences (ZHAW Wädenswil). The group is also part of Swiss Institute of Bioinformatics, which provides additional training and networking opportunities.

The collaboration is between ZHAW, University of Bern, ETH Zurich and IBM.

The candidates will also contribute within the EU COST Action CA17118 and MSCA RISE network:

Profile requirements

- PhD/ MSc degree in bioinformatics, computational biology, computational science, statistics, or similar

- Working knowledge of programming languages such as Python, C++

- Some knowledge of phylogenetics and modeling molecular evolution is as advantage

- Active research attitude

- Excellent presentation and communication skills

Start date: 01 Jan 2022

Job reference: CRC-STR

How to apply
If you are interested in this challenging and highly interesting position, please send your application including CV and letter of motivation to Dr. Maria Anisimova at